down arrow

Alpa Laboratorie

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE385I01010
  • NSEID: ALPA
  • BSEID: 532878
INR
105.60
4.05 (3.99%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 14.89 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Alpa Laboratories Ltd stock-summary
stock-summary
Alpa Laboratories Ltd
Micro Cap
Pharmaceuticals & Drugs
M/s Alpa Laboratories, formed in 1967, was incorporated as Private Limited Company in the name of Alpa Laboratories Private Limited on March 18, 1988 for manufacture of pharmaceutical formulations. In 1998, the Company was converted into a Public Limited Company with effect from September 3, 1998 with the name of "Alpa Laboratories Limited".
Company Coordinates stock-summary
Company Details
33/2 Pigdamber, A B Road Rau Indore Madhya Pradesh : 453446
stock-summary
Tel: 91-731-4294567
stock-summary
is@alpalabs.com
Registrar Details
Bigshare Services Pvt Ltd , E-2 , Ansa Industrial Estate, Saki Vihar Road, Saki Naka, Andheri (E), Mumbai
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR 21.04 Cr
Number of Shares
2.1 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
06-Aug-2007
2.1
21.04
8980600
10
Public Issues
06-Aug-2007
2.1
21.04
8980600
10
Public Issues
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 1 FIIs (0.35%)

Promoter with highest holding

Paresh Chawla (17.52%)

Highest Public shareholder

None

Individual Investors Holdings

36.8%

stock-summary Board of Directors
stock-summary
stock-summary
Management
Designation
Remuneration
Mahendra Singh Chawla
Chairman & Exec. Director
84.0 lacs
Pravin C Shah
Executive Director
43.2 lacs
Sharad Chand Lunawat
Independent Director
10.0 k
Devendra Baheti
Independent Director
50.0 k
Krishna Das Malani
Independent Director
50.0 k
Paresh Chawla
Managing Director
84.0 lacs
Jyoti Jain
Independent Director
40.0 k
Swati Bagh
Company Sec. & Compli. Officer
0
Vitthal Kothana
Executive Director
0
SUNIL VALECHA
Additional Director
0
Saket Baheti
Independent Director
0
Pratibha Lunawat
Independent Director
0
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
Purchase of stock in Trade
5.824
0%
 
100
Purchase of stock in Trade
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Drugs and Pharmaceuticals
61.05
98.04%
Export Incentives
0.88
1.41%
Income from Analytical , Job work & Conversion & Packing Charges
0.25
0.41%
 
98.04
Drugs and Pharmaceuticals
1.96
Drugs and Pharmaceuticals
1.41
Export Incentives
98.59
Export Incentives
0.41
Income from Analytical , Job work & Conversion & Packing Charges
99.59
Income from Analytical , Job work & Conversion & Packing Charges
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
26 Cr
(Quarterly Results - Dec 2024)
Net Profit:
9 Cr
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 222 Cr (Micro Cap)

stock-summary
P/E

8.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.65

stock-summary
Return on Equity

12.65%

stock-summary
Price to Book

1.30